Finance entity
Of the tracked stories, 1 of 2 also mention Arbe Robotics, the most common co-covered peer. Across a 7-day span, the pace is roughly 2 stories per week. Their average consequence score of 5 runs below the beat's 6.2 for that window.
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention Arbe Robotics, the most common co-covered peer. Across a 7-day span, the pace is roughly 2 stories per week. Their average consequence score of 5 runs below the beat's 6.2 for that window. The clearest coverage concentration is earnings: 1 of 2 stories, with the rest divided among 1 other category. Source depth averages 3 original sources per story, versus 2.6 across the same-window beat baseline. This profile follows 2 Finance stories mentioning Vir Biotechnology across the period from February 20, 2026 to February 26, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 542 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Vir Biotechnology. Shared-story counts are live from our verified record — not editorial picks.
A surge in interest for robotics and specialized small-cap stocks highlights a shift toward automation and niche AI applications. Investors are balancing high-growth robotics plays like Teradyne and Serve Robotics against leveraged volatility in semiconductor and software sectors.
Source: Daily Political · Markets Daily
A wave of fourth-quarter earnings previews for mid-cap biotech and genetic testing firms highlights a critical juncture for clinical-stage pipelines and commercial scaling. Investors are particularly focused on Summit Therapeutics' bispecific antibody progress and BioMarin's strategic pivot toward profitability.
Vir Biotechnology is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
